Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
ACI Global Corp | 320.0 | 0.0x | --- |
Genelink Inc | 2.7K | 0.0x | --- |
Diego Pellicer Worldwide Inc | 26.1K | 0.0x | --- |
Arboreta Healthcare Inc | 13.7K | --- | --- |
Wellbeing Digital Sciences Inc | 130.0 | 0.0x | --- |
ER Urgent Care Holdings Inc | 40.0 | 0.0x | --- |
ACI Global Corp., formerly Par Advance Technologies Corp., a clinical-stage biopharmaceutical company engaged in the development of natural and novel peptides for the treatment or prevention of infections due to multi-drug resistant bacteria and fungi. The Company's drug candidates are proprietary synthetic and natural peptides (small proteins). Antecedents for these compounds occur in nature as part of the immune system of animals, insects and plants. Generally, the peptides bind to and kill harmful microorganisms and cancer cells. P113D, the Company's product candidate for cystic fibrosis, has been awarded Orphan Drug designation by the United States Food and Drug Administration (FDA). Demegen is also developing a novel, synthetic antimicrobial peptide in a rinse formulation for the treatment and prevention of oral candidiasis. The Company's peptide technology can also be used to prevent serious damage to crops caused by fungal and bacterial diseases.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $320.00 |
---|---|
Revenue (TTM) | $1.2M |
Shares Outstanding | 320.9M |
ACI Global Corp does not pay a dividend. | |
Beta | --- |
EPS | $-1.10 |
Book Value | $-2.75 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -92.99% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.